secwatch / observer
8-K filed March 15, 2023, 7:59 PM ET ticker HLYK CIK 0001680139
leadership confidence high sentiment neutral materiality 0.30

HealthLynked appoints Paul J. Hobaica, MD to board; Robert Mino resigns

HealthLynked Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul J. Hobaica, M.D.

Director
HLYK · HealthLynked Corp
Effective
2023-03-13
Filed
March 15, 2023, 7:59 PM ET
On March 13, 2023, the Board appointed Paul J. Hobaica, M.D. as a director of the Company, effective immediately, to fill the vacancy created by Robert Mino’s resignation.
Departed

Robert Mino

Director
HLYK · HealthLynked Corp
Effective
2023-03-13
Successor
Paul J. Hobaica, M.D.
Filed
March 15, 2023, 7:59 PM ET
On March 13, 2023, the Board of Directors (the “ Board ”) of HealthLynked Corp., a Nevada corporation (the “ Company ”) accepted independent director Robert Mino’s resignation, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul J. Hobaica, M.D. was appointed as Director at HealthLynked Corp.

Action
appointed
Role
Director
Exact text from the filing
On March 13, 2023, the Board appointed Paul J. Hobaica, M.D. as a director of the Company, effective immediately, to fill the vacancy created by Robert Mino’s resignation.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Mino resigned as Director at HealthLynked Corp.

Action
resigned
Role
Director
Exact text from the filing
On March 13, 2023, the Board of Directors (the “ Board ”) of HealthLynked Corp., a Nevada corporation (the “ Company ”) accepted independent director Robert Mino’s resignation, effective immediately.
View on SEC.gov

HealthLynked Corp filing history →

Source: SEC EDGAR
accession 0001213900-23-020304
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.